Impact of vascular apoE in aging and AD
血管apoE对衰老和AD的影响
基本信息
- 批准号:10667475
- 负责人:
- 金额:$ 54.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAffectAgeAge MonthsAgingAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAmyloidAmyloid beta-ProteinApoE knockout mouseApolipoprotein EAstrocytesAtherosclerosisBiochemistryBioinformaticsBiological MarkersBiologyBiometryBlood - brain barrier anatomyBlood VesselsBrainBrain imagingBreedingCell modelCell physiologyCellsCerebral Amyloid AngiopathyCerebrovascular CirculationCerebrovascular DisordersCerebrovascular systemCognitionCollaborationsCouplingDNA cassetteDevelopmentElderlyEnsureExcisionGenesGenotypeGoalsHomeostasisHumanImmune responseImmune systemImpaired cognitionIndividualKnock-in MouseKnock-outKnockout MiceLipoproteinsLiquid substanceLoxP-flanked alleleMeasuresMediatingMetabolismMicrogliaModelingMolecularMolecular ProfilingMusNerve DegenerationNeurogliaOutcomePathogenesisPathogenicityPathologicPathway interactionsPericytesPhasePhenotypePlasmaPlayPropertyProtein IsoformsProteomicsResourcesRisk FactorsRoleSamplingSeveritiesSmooth Muscle MyocytesStatistical Data InterpretationStructural ModelsStudy modelsTestingVascular Cognitive ImpairmentWhite Matter Hyperintensityage relatedamyloid pathologyapolipoprotein E-3beta amyloid pathologybrain parenchymacell typecerebrovascularcognitive functioncognitive performancecomparativedata managementglycationhypercholesterolemiainduced pluripotent stem cellinnovationlipid metabolismlipid transportlipidomicsmetabolomicsmolecular phenotypemouse modelmultiple omicsneuroinflammationneuropathologynoveloxidationparticlepromotersingle-cell RNA sequencingwhite matter damage
项目摘要
PROJECT SUMMARY (APOE U19: Project 4)
While the major function of apolipoprotein E (apoE) is to mediate the lipid transport, APOE genotype (APOE2,
APOE3 and APOE4) significantly influences cognitive function and Alzheimer’s disease (AD) pathogenesis
through multiple pathways. APOE is associated with not only amyloid-β (Aβ) pathology but also cerebrovascular
function including blood-brain barrier integrity and cerebral blood flow. Given that cerebrovascular disturbance
substantially contributes to cognitive decline in the elderly and that apoE is abundantly expressed in vascular
mural cells (smooth muscle cells and pericytes) as well as astrocytes and microglia in the brain, the overall goal
of Project 4 is to define how APOE genotype in vascular mural cells impacts the molecular mechanisms and
pathways in the development of cerebrovascular dysregulations and cognitive decline during aging and AD. In
Aim 1, we will utilize novel mouse models, in which human APOE2, APOE3, or APOE4 gene is expressed upon
an excision of a loxp-flanked STOP cassette by vascular mural cell specific sm22α promoter driven Cre
expression to determine the effects of vascular mural cell-specific expression of apoE isoforms on
cerebrovascular function and brain cognition during aging. In Aim 2, we will define the impact of apoE isoform
deletion in vascular mural cells on age-related cerebrovascular dysfunction and cognitive decline using novel
APOE knock-in mice, in which murine Apoe is replaced with floxed APOE2, APOE3, or APOE4 gene. By
crossing with sm22α-Cre mice, we will specifically delete individual apoE isoforms in vascular mural cells. In Aim
3, we will examine how vascular-specific expression or deletion of apoE isoforms in conditional mouse models
affects AD-related phenotypes by breeding the vascular mural cell-specific apoE isoform expressing or knockout
mice with amyloid model APP knockin mice (AppNL-F/NL-F). Using those unique mouse models, we will
comprehensively investigate how apoE isoforms in vascular mural cells impact cerebrovascular function, glial
phenotypes, neuroinflammation, neurodegeneration, brain cognition and amyloid pathology at different ages. In
particular, the apoE properties in the mouse models will be analyzed by the Biochemistry and Structural
Modeling Core (Core B). ApoE amounts, oxidation and/or glycation in the mice as well as other AD-rerated fluid
biomarkers will be measured through the Biomarker Core (Core D). While neuropathology in the mice will be
investigated in Neuropathology Core (Core C), a multi-Omics approach including proteomics, metabolomics,
lipidomics and single cell RNA sequencing will be carried out through the Multi-Omics Core (Core F) and
Bioinformatics, Biostatistics, and Data Management Core (Core G) to profile molecular phenotypes in these
mouse models. Together, our innovative study should fill a critical void in our understanding of how apoE
isoforms in cerebrovasculature impact cellular functions and brain homeostasis during aging and AD through
synergistic interaction with Core B-G and comparative mouse model studies by Project 2 and Project 3.
项目摘要(APOE U19:项目 4)
虽然载脂蛋白 E (apoE) 的主要功能是介导脂质转运,但 APOE 基因型 (APOE2、
APOE3 和 APOE4 显着影响认知功能和阿尔茨海默病 (AD) 发病机制
APOE 不仅与淀粉样蛋白 (Aβ) 病理有关,还与脑血管有关。
功能包括血脑屏障完整性和脑血流量。
apoE 在很大程度上导致老年人认知能力下降,并且 apoE 在血管中大量表达
壁细胞(平滑肌细胞和周细胞)以及大脑中的星形胶质细胞和小胶质细胞,总体目标
项目 4 的目的是定义血管壁细胞中的 APOE 基因型如何影响分子机制和
衰老和 AD 期间脑血管失调和认知能力下降的发展途径。
目标1,我们将利用新的小鼠模型,其中表达人类APOE2、APOE3或APOE4基因
通过血管壁细胞特异性 sm22α 启动子驱动的 Cre 切除 loxp 侧翼的 STOP 盒
表达以确定 apoE 亚型的血管壁细胞特异性表达对
在目标 2 中,我们将定义 apoE 同工型的影响。
血管壁细胞缺失对年龄相关脑血管功能障碍和认知能力下降的影响
APOE 敲入小鼠,其中小鼠 Apoe 被 floxed APOE2、APOE3 或 APOE4 基因取代。
与 sm22α-Cre 小鼠杂交,我们将专门删除血管壁细胞中的单个 apoE 同工型。
3、我们将研究条件小鼠模型中apoE亚型的血管特异性表达或缺失如何
通过培育血管壁细胞特异性 apoE 亚型表达或敲除来影响 AD 相关表型
淀粉样蛋白模型 APP 敲入小鼠 (AppNL-F/NL-F),我们将使用这些独特的小鼠模型。
全面研究血管壁细胞apoE亚型如何影响脑血管功能、神经胶质细胞
不同年龄的表型、神经炎症、神经变性、大脑认知和淀粉样蛋白病理。
特别是,小鼠模型中的 apoE 特性将通过生物化学和结构分析进行分析
模拟核心(核心 B)小鼠中的 ApoE 含量、氧化和/或糖化以及其他 AD 相关液体。
生物标记物将通过生物标记物核心(Core D)进行测量,而小鼠的神经病理学将被测量。
神经病理学核心(核心 C)进行了研究,这是一种多组学方法,包括蛋白质组学、代谢组学、
脂质组学和单细胞 RNA 测序将通过多组学核心(Core F)和
生物信息学、生物统计学和数据管理核心 (Core G),用于分析这些领域的分子表型
总之,我们的创新研究应该填补我们对 apoE 如何理解的一个关键空白。
脑血管系统中的亚型通过以下方式影响衰老和 AD 过程中的细胞功能和大脑稳态
与 Core B-G 的协同相互作用以及项目 2 和项目 3 的比较小鼠模型研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Takahisa Kanekiyo其他文献
Takahisa Kanekiyo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Takahisa Kanekiyo', 18)}}的其他基金
Therapeutic Strategy to Treat Alzheimer's Disease by VGF Delivery into Brain
通过将 VGF 输送至大脑来治疗阿尔茨海默病的治疗策略
- 批准号:
10738951 - 财政年份:2023
- 资助金额:
$ 54.78万 - 项目类别:
Neuronal ABCA7 loss of function and Alzheimer’s disease
神经元 ABCA7 功能丧失与阿尔茨海默病
- 批准号:
10629715 - 财政年份:2023
- 资助金额:
$ 54.78万 - 项目类别:
Enhanced APOE2 Expression into Brain for Therapeutic Strategy for Alzheimer's Disease
增强 APOE2 在大脑中的表达,用于阿尔茨海默病的治疗策略
- 批准号:
10514954 - 财政年份:2021
- 资助金额:
$ 54.78万 - 项目类别:
Enhanced APOE2 Expression into Brain for Therapeutic Strategy for Alzheimer's Disease
增强 APOE2 在大脑中的表达,用于阿尔茨海默病的治疗策略
- 批准号:
10208342 - 财政年份:2021
- 资助金额:
$ 54.78万 - 项目类别:
Enhanced APOE2 Expression into Brain for Therapeutic Strategy for Alzheimer's Disease
增强 APOE2 在大脑中的表达,用于阿尔茨海默病的治疗策略
- 批准号:
10514954 - 财政年份:2021
- 资助金额:
$ 54.78万 - 项目类别:
相似国自然基金
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
运动状态下代谢率的年龄变化特征及对人体热舒适的影响研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
基于堆叠式集成学习探索人居环境对生物学年龄的影响
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Causes and Downstream Effects of 14-3-3 Phosphorylation in Synucleinopathies
突触核蛋白病中 14-3-3 磷酸化的原因和下游影响
- 批准号:
10606132 - 财政年份:2024
- 资助金额:
$ 54.78万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 54.78万 - 项目类别:
Regulation of Vascular Calcification by Adventitial Endothelial Cells
外膜内皮细胞对血管钙化的调节
- 批准号:
10642619 - 财政年份:2023
- 资助金额:
$ 54.78万 - 项目类别:
The role of adverse community-level policing exposure on disparities in Alzheimer's disease related dementias and deleterious multidimensional aging
社区层面的不良警务暴露对阿尔茨海默病相关痴呆和有害的多维衰老差异的作用
- 批准号:
10642517 - 财政年份:2023
- 资助金额:
$ 54.78万 - 项目类别:
Maternal inflammation in relation to offspring epigenetic aging and neurodevelopment
与后代表观遗传衰老和神经发育相关的母体炎症
- 批准号:
10637981 - 财政年份:2023
- 资助金额:
$ 54.78万 - 项目类别: